{"success":true,"title":{"id":"353544","title":"Comunicado de Seguridad de Farmacovigilancia N\u00ba 16-2022. S\u00edndrome mano-pie inducido por f\u00e1rmacos quimioter\u00e1picos","author":"Seguro Social de Salud (EsSalud). Instituto de Evaluaci\u00f3n de Tecnolog\u00edas en Salud e Investigaci\u00f3n (IETSI). Direcci\u00f3n de Gu\u00edas de Pr\u00e1ctica Cl\u00ednica, Farmacovigilancia y Tecnovigilancia. Centro de Referencia Institucional de Farmacovigilancia y Tecnovigilancia (CRI-EsSalud)","isbn":null,"issn":null,"publisher":"Seguro Social de Salud (EsSalud)","publication_year":"2022","resource_url":"","abstract_text":"El s\u00edndrome mano pie es referido a una manisfestaci\u00f3n cl\u00ednica cutanea que incluye: distesia y\/o parestesia y eritema palmoplantar y se encuentra asociado a f\u00e1rmos quimoterap\u00e9uticos generando un impacto negativo en la calidad de vida del paciente, por lo que su manejo debe ser tratado adecuadamente.","resource_type":"publication","country":"Europe","language_code":"spa","keywords":"OpenAIRE; Research Graph; publications; Inhibidores de prote\u00ednas quinasas; S\u00edndrome mano-pie; Carcinoma de c\u00e9lulas renales; Antineopl\u00e1sicos; https:\/\/purl.org\/pe-repo\/ocde\/ford#3.02.20; instname:Seguro Social de Salud; instacron:ESSALUD; reponame:ESSALUD-Institucional","source_name":"OpenAIRE","kbart_publication_title":null,"kbart_print_identifier":null,"kbart_online_identifier":null,"kbart_title_url":null,"kbart_first_author":null,"kbart_publisher_name":null,"kbart_publication_type":null,"marcxml":null,"created_at":"2026-06-13 12:01:22","updated_at":"2026-06-13 12:01:22","provider_id":"31","collection_id":"36","availability_status":"open_access","access_model":"open_access","regional_availability":null,"subtitle":null,"edition_statement":null,"publication_place":null,"physical_description":null,"pages":null,"doi":"","lcc_code":null,"ddc_code":null,"cdu_code":null,"rda_content_type":null,"rda_media_type":null,"rda_carrier_type":null,"cataloging_status":"metadata_imported","cataloging_notes":null,"cataloging_source":"OpenAIRE","cataloger_name":null,"validated_at":null,"marc_control_number":null,"source_format":"api_json","source_file":null,"marc_leader":null,"url":"","subjects":"Inhibidores de prote\u00ednas quinasas; S\u00edndrome mano-pie; Carcinoma de c\u00e9lulas renales; Antineopl\u00e1sicos; https:\/\/purl.org\/pe-repo\/ocde\/ford#3.02.20","client_id":"1","import_job_id":null,"metadata_quality_score":null,"metadata_quality_level":null,"metadata_quality_checked_at":null,"suggested_language":null,"suggested_subjects":null,"suggested_ddc":null,"suggested_lcc":null,"suggested_cdu":null,"enrichment_status":null,"enrichment_checked_at":null,"marc_source_type":null,"marc_quality_status":null,"marc_is_express":"0","marc_source_note":null,"marc_export_allowed":"0"},"result":{"access":false,"title_id":353544,"institution_id":0,"best":null,"holdings":[],"message":"Sin acceso resuelto. El registro existe, pero no hay holding\/URL activa para abrir el recurso.","openurl":{"genre":"","doi":"","isbn":"","issn":"","title":"","atitle":"","jtitle":"","stitle":"","sid":"","date":"","volume":"","issue":"","spage":"","epage":""}}}